正文
靶向Claudin18.2 CAR-T细胞（Satri-cel）疗法对比医生选择治疗方案（TPC）用于经治晚期胃癌或胃食管结合部癌（G/GEJC）的疗效：一项随机、开放标签II期临床试验（CT041-ST-01）的初步结果
摘要号：
LBA4004
报告人：
Michele Reni | Department of Medical Oncology, Pancreas Translational and Clinical Research Center, IRCCS San Raffaele Scientific Institute, Vita-Salute San Raffaele University
英文标题：
Results of a randomized phase III trial of pre-operative chemotherapy with mFOLFIRINOX or PAXG regimen for stage I-III pancreatic ductal adenocarcinoma.
中文标题：
术前mFOLFIRINOX或PAXG方案化疗用于I-III期胰腺导管腺癌的随机III期临床试验结果
摘要号：
LBA4005
报告人：
Vincent J. Picozzi | Virginia Mason Medical Center
英文标题：
PANOVA-3: Phase 3 study of tumor treating fields (TTFields) with gemcitabine and nab-paclitaxel for locally advanced pancreatic ductal adenocarcinoma (LA-PAC).
中文标题：
PANOVA-3：肿瘤治疗电场（TTFields）联合吉西他滨和白蛋白结合型紫杉醇治疗局部晚期胰腺导管腺癌（LA-PAC）的3期研究
摘要号：
4006
报告人：
Devalingam Mahalingam | Robert H. Lurie Comprehensive Cancer Center, Northwestern University
英文标题：
Preliminary results from the randomized phase 2 study (1801 part 3B) of elraglusib in combination with gemcitabine/nab-paclitaxel (GnP) versus GnP alone in patients (pts) with previously untreated metastatic pancreatic ductal adenocarcinoma (mPDAC).
中文标题：
Elraglusib联合吉西他滨/白蛋白结合型紫杉醇（GnP）对比单纯GnP方案治疗初治转移性胰腺导管腺癌（mPDAC）患者的随机2期研究（1801 part 3B）初步结果
摘要号：
4007
报告人：
Reena Engineer | Tata Memorial Centre (HBNI)
英文标题：
A phase III randomized clinical trial evaluating perioperative therapy (neoadjuvant chemotherapy versus chemoradiotherapy) in locally advanced gallbladder cancers (POLCAGB).
中文标题：
POLCAGB研究：局部晚期胆囊癌围手术期治疗（新辅助化疗对比放化疗）的III期随机临床试验
摘要号：
4008
报告人：
Thorsten Oliver Goetze | Institute of Clinical Cancer Research (IKF), Krankenhaus Nordwest, UCT-University Cancer Center
英文标题：
Neoadjuvant chemotherapy with gemcitabine plus cisplatin followed by radical liver resection versus immediate radical liver resection alone followed adjuvant therapy in biliary tract cancer: Final results from the phase III AIO/CALGP/ACO-GAIN-Trial.
中文标题：
吉西他滨联合顺铂新辅助化疗后根治性肝切除术对比直接根治性肝切除术联合辅助治疗用于胆道癌的III期临床研究（AIO/CALGP/ACO-GAIN试验）最终结果
